siRNA, Anti-CHCHD2, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT76139WQ-2OMe)

The product SIRGT76139WQ-2OMe is a type of small interfering RNA (siRNA) that targets CHCHD2 gene and regulates the expression of gene. The siRNA interferes with the expression of CHCHD2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_016139.3
Alternative Names C7orf17; MNRR1; NS2TP; PARK22
Related Diseases Parkinson Disease 22, Autosomal Dominant
Purification HPLC
Target Gene
Gene ID 51142
Uniprot ID Q9Y6H1
Sub Cat Target Species Modification Scale  
SIRGT77139WQ-2F CHCHD2 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT78139WQ-2MOE CHCHD2 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT79139WQ-LNA CHCHD2 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT76139WQ-RB CHCHD2 Human Ribo-modified Inquiry
SIRGT77139WQ-BB CHCHD2 Human Backbone-modified Inquiry

Related Products